SOSzymon Olędzki

Szymon Olędzki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Szymon Olędzki has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Edyta Płońska-Gościniak

    Pomeranian Medical University

    4 shared publications
  • Andrzej Wojtarowicz

    Department of Cardiology, Pomeranian Medical University, Szczecin, Poland

    3 shared publications
  • Edyta Płońska-Gościniak

    Department of Cardiology, Pomeranian Medical University, Szczecin, Poland

    3 shared publications
  • Jarosław Gorący

    Department of Cardiology, Pomeranian Medical University, Szczecin, Poland

    3 shared publications
  • Jarosław Kaźmierczak

    Department of Cardiology, Pomeranian Medical University, Szczecin, Poland

    3 shared publications
  • Piotr Gościniak

    Independent Laboratory of Non-Invasive Heart Diagnostics for Children and Adults, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Szczecin, Poland; Department of Endocrinology, Metabolic Diseases and Internal Diseases, Pomeranian Medical University in Szczecin, Szczecin, Poland

    3 shared publications

Latest Publications

  • Thermographic assessment of skin temperature changes at the incision site following cardiac implantable electronic device implantation: A pilot study

    by Szymon OlęDzki, Wilhelm Grzesiak, Daniel Zaborski, Agnieszka Pietruszczak, Jarosław Kaźmierczak, Andrzej Modrzejewski

  • Open Access

    Serum Zonulin and Lipopolysaccharide (LPS) Levels in Early Myocardial Infarction: Association with Left Ventricular Ejection Fraction

    by Szymon Olędzki, Arnold Kukowka, Aldona Siennicka, Natalia Jakubiak, Dominika Maciejewska-Markiewicz, Radosław Kiedrowicz, Jarosław Kaźmierczak

    Background: Atherosclerosis is the main cause of coronary heart disease, which frequently precedes the onset of heart failure. Lipopolysaccharide (LPS), a pro-inflammatory endotoxin produced by Gram-negative bacteria, exacerbates atherosclerotic processes and negatively impacts myocardial function, particularly in the context of activating low grade inflammation. Zonulin, a key regulator of the blood-gut barrier, modulates tight junction permeability, potentially facilitating the translocation of microbial-derived compounds, including LPS, into the circulation. Given these interactions, we investigated serum levels of lipopolysaccharide and zonulin in patients following myocardial infarction. This study aimed to assess serum levels of zonulin and lipopolysaccharide (LPS) in patients who had experienced a myocardial infarction (MI) and to evaluate the association between these biomarkers and ejection fraction (EF) across different patient groups. Methods: 78 patients (22 women and 56 men) diagnosed with MI, who underwent primary PCI (percutaneous coronary intervention), were included in the study. The blood samples were collected between 24 and 48 h after PCI. Results: Post-myocardial infarction patients with an ejection fraction ≤ 40% exhibited significantly elevated serum lipopolysaccharide levels compared to those with an ejection fraction > 40%. However, no significant differences in zonulin levels were observed between the study groups. Conclusions: Our findings suggest that elevated serum lipopolysaccharide levels may be associated with a reduction in post-infarction ejection fraction. This observation highlights a potential link between endotoxemia and impaired myocardial function following MI, warranting further investigation.


  • Open Access

    Intraventricular septal hematoma as a complication of left bundle branch pacing: A case report of evolution of hematoma after conservative treatment

    by Szymon Olędzki, Radosław Kiedrowicz, Maciej Wielusiński, Edyta Płońska-Gościniak, Jarosław Kaźmierczak


  • Open Access

    Hematoma of the interatrial septum after surgery for a giant aneurysm of the sinus of Valsalva

    by Jerzy Pacholewicz, Andrzej Żych, Szymon Olędzki, Edyta Płońska-Gościniak


  • Open Access

    Intracardiac pseudotumor: Caseous calcification of the mitral annulus on multimodality imaging

    by Szymon Olędzki, Piotr Gościniak, Andrzej Żych, Małgorzata Peregud-Pogorzelska, Edyta Płońska-Gościniak

    W w w. j o u r n a l s. v i a m e d i c a. p l / k a r d i o l o g i a _ p o l s k a 302


  • Pol-CDRIE registry – 1-year observational data on patients hospitalized due to cardiac device-related infective endocarditis in Polish referential cardiology centres

    by Edyta Płońska-Gościniak, Szymon Olędzki, Tomasz Kukulski, Wojciech Kosmala, Rafał Młynarski, Zofia Oko-Sarnowska, Agnieszka Wojtkowska, Piotr Gościniak, Zbigniew Gąsior, Tomasz Hryniewiecki, et al.

    BACKGROUND The rate of cardiac device-related infective endocarditis (CDRIE) is increasing worldwide, but no detailed data are available for Poland. AIMS We aimed to evaluate clinical, diagnostic, and therapeutic data of patients hospitalized due to CDRIE in 22 Polish referential cardiology centers from May 1, 2016 to May 1, 2017. METHODS Participating cardiology departments were asked to fill in a questionnaire that included data on the number of hospitalized patients, number and types of implanted cardiac electrotherapy devices, and number of infective endocarditis cases. We also collected clinical data and data regarding the management of patients with CDRIE. RESULTS Overall, 99621 hospitalizations were reported. Infective endocarditis unrelated to cardiac device was the cause of 596 admissions (0.6%), and CDRIE, of 195 (0.2%). Pacemaker was implanted in 91 patients with CDRIE (47%); cardioverter-defibrillator, in 51 (26%); cardiac resynchronization therapy-defibrillator, in 48 (25%); and cardiac resynchronization therapy-pacemaker, in 5 (2.5%). The most common symptoms were malaise (62%), fever/chills (61%), cough (21%), chest pain (19.5%), and inflammation of the device pocket (5.6%). Cultures were positive in 77.5% of patients. The cardiac device was removed in 91% of patients. The percutaneous approach was most common for cardiac device removal. All patients received antibiotic therapy, and 3 patients underwent a heart valve procedure. Transesophageal echocardiography was performed in 80% of patients. The most common complication was heart failure (25% of patients). CONCLUSIONS The clinical profile, pathogen types, and management strategies in Polish patients with CDRIE are consistent with similar data from other European countries. Transesophageal echocardiography was performed less frequently than recommended. The removal rate in the Polish population is consistent with the general rates observed for interventional treatment in patients with CDRIE.


  • Open Access

    Polish Stress Echocardiography Registry (Pol-STRESS registry) — a multicentre study. Stress echocardiography in Poland: numbers, settings, results, and complications

    by Edyta Płońska-Gościniak, Jarosław D. Kasprzak, Szymon Olędzki, Jolanta Rzucidło-Resil, Piotr Gościniak, Tomasz Kukulski, Katarzyna Mizia-Stec, Wojciech Kosmala, Dariusz Kosior, Marta Marcinkiewicz-Siemion, et al.

    Background: Stress echocardiography (SE) is widely used in Europe. No collective data have been available on the use of SE in Poland until now. Aim: To evaluate the number of SE investigations performed in Poland, their settings, complications and results. Methods: In this retrospective survey, referral cardiology centers in Poland were asked to fill in a questionnaire regarding SE examinations performed from May 01, 2014 to May 01, 2015. Results: The study included data from 17 university hospitals and large community hospitals which performed 4611 SE examinations, including 4408 tests in patients investigated for coronary artery disease (CAD) and 203 tests to evaluate valvular heart disease (VHD). To evaluate CAD, all centers performed dobutamine SE (100%), 10 centers performed pacing SE (58.8%), while cycle ergometer SE and treadmill SE were performed by 6 (35.3%) and 5 (29.4%) centers, respectively. Dipyridamole SE was performed in one center. All evaluated centers (100%) performed SE to evaluate low-flow/low-gradient aortic stenosis (LFLG-AS), eight (47%) performed SE to evaluate asymptomatic aortic stenosis, and also eight (47%) performed SE to evaluate mitral regurgitation. The mean number of examinations per year was 271 per center. Most centers performed more than 100 examinations per year (11 centers, 64.7%). We did not identify any cardiac death during SE examination in any of the centers. Myocardial infarction occurred in 3 (0.07%) patients. Nonsustained ventricular tachycardia occurred in 52 (1.1%) SE examinations. The rates of minor complications were low. SE to evaluate CAD was more commonly performed in hospital settings using cycle ergometer (72.6%), treadmill (87.6%), and low-dose dobutamine (68.0%), while a dipyridamole test was more frequently employed in ambulatory patients (77.6%). No significant differences between the rates of examinations performed in ambulatory and hospital settings were found for high-dose dobutamine and pacing SE. Examinations to evaluate VHD were significantly more frequently performed in hospital settings. SE examinations amounted to more than one third of all stress tests performed in the surveyed centers over the study period. Conclusions: SE is a safe diagnostic method, and major complications are very rare. Despite European recommendations, SE examinations to evaluate CAD are performed less frequently than electrocardiographic exercise tests, although they already comprise a significant proportion of all stress tests. It seems reasonable to promote SE further for the evaluation of both CAD and VHD. Background: Stress echocardiography (SE) is widely used in Europe. No collective data have been available on the use of SE in Poland until now. Aim: To evaluate the number of SE investigations performed in Poland, their settings, complications and results. Methods: In this retrospective survey, referral cardiology centers in Poland were asked to fill in a questionnaire regarding SE examinations performed from May 01, 2014 to May 01, 2015. Results: The study included data from 17 university hospitals and large community hospitals which performed 4611 SE examinations, including 4408 tests in patients investigated for coronary artery disease (CAD) and 203 tests to evaluate valvular heart disease (VHD). To evaluate CAD, all centers performed dobutamine SE (100%), 10 centers performed pacing SE (58.8%), while cycle ergometer SE and treadmill SE were performed by 6 (35.3%) and 5 (29.4%) centers, respectively. Dipyridamole SE was performed in one center. All evaluated centers (100%) performed SE to evaluate low-flow/low-gradient aortic stenosis (LFLG-AS), eight (47%) performed SE to evaluate asymptomatic aortic stenosis, and also eight (47%) performed SE to evaluate mitral regurgitation. The mean number of examinations per year was 271 per center. Most centers performed more than 100 examinations per year (11 centers, 64.7%). We did not identify any cardiac death during SE examination in any of the centers. Myocardial infarction occurred in 3 (0.07%) patients. Nonsustained ventricular tachycardia occurred in 52 (1.1%) SE examinations. The rates of minor complications were low. SE to evaluate CAD was more commonly performed in hospital settings using cycle ergometer (72.6%), treadmill (87.6%), and low-dose dobutamine (68.0%), while a dipyridamole test was more frequently employed in ambulatory patients (77.6%). No significant differences between the rates of examinations performed in ambulatory and hospital settings were found for high-dose dobutamine and pacing SE. Examinations to evaluate VHD were significantly more frequently performed in hospital settings. SE examinations amounted to more than one third of all stress tests performed in the surveyed centers over the study period. Conclusions: SE is a safe diagnostic method, and major complications are very rare. Despite European recommendations, SE examinations to evaluate CAD are performed less frequently than electrocardiographic exercise tests, although they already comprise a significant proportion of all stress tests. It seems reasonable to promote SE further for the evaluation of both CAD and VHD.


  • Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention

    by Szymon Olędzki, Zdzisława Kornacewicz-Jach, Krzysztof Safranow, Radosław Kiedrowicz, Barbara Gawrońska-Szklarz, Maria Jastrzębska, Jarosław Gorący

    Antiplatelet response to clopidogrel and its influence upon the risk of cardiovascular adverse events among patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) has not been investigated fully.


  • Scuba diving, patent foramen ovale and heart rhythm disturbances: The role of underwater Holter monitoring—Case report

    by Szymon Olędzki, Andrzej Wojtarowicz, Edyta Płońska‐Gościniak, Maciej Lewandowski, Jarosław Gorący

    Patent foramen ovale (PFO) is thought to be a risk factor for decompression illness (DCI). Catheter‐based closure procedure reduces the risk of DCI in selected scuba divers with PFO. Major complication of invasive approach are rare, minor, especially heart rhythm disturbances are reported relatively often. We describe a case of 41‐year‐old diver, who underwent PFO closure due to recurrent DCI events. Afterward, he experienced no DCI symptoms; however, he complained about feeling of the heart beating during a submersion. Arrhythmia should be considered as a life‐threatening for scuba diver, thus we performed underwater ECG monitoring and exclude the arrhythmia.